Showing results (71-80 of 156) with videos related to
Sort By:
Pageof 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 11, 2006
[A randomized controlled trial to evaluate the effect of adjuvant oral fluoropyrimidine derivative therapy after curative resection for stage II/III rectal cancer-adjuvant chemotherapy trial of S-1 for rectal cancer (ACTS-RC):]Eiji Oki, Yoshihiro Kakeji, Rintaro Yoshida, et al.Breast Cancer (Tokyo, Japan)|July 1, 2020
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancerWakako Tajiri, Hideki Ijichi, Katsumi Takizawa, et al.International Journal of Cancer|July 29, 2005
Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patientsEriko Tokunaga, Yasue Kimura, Eiji Oki, et al.International Journal of Clinical and Experimental Pathology|August 15, 2014
Spontaneous regression of breast cancer with axillary lymph node metastasis: a case report and review of literatureEriko Tokunaga, Shinji Okano, Yuichiro Nakashima, et al.Breast Cancer Research and Treatment|February 28, 2006
Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancerEriko Tokunaga, Eiji Oki, Kojiro Nishida, et al.European Journal of Radiology|September 12, 2006
MR imaging features of pure mucinous carcinoma of the breastTakashi Okafuji, Hidetake Yabuuchi, Shuji Sakai, et al.Breast Cancer (Tokyo, Japan)|January 14, 2014
Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive/HER2-negative breast cancerYuichi Hisamatsu, Eriko Tokunaga, Nami Yamashita, et al.Respirology Case Reports|March 8, 2024
Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapyHiroaki Ogata, Chinami Koga, Toyoshi Yanagihara, et al.Cancer Medicine|October 25, 2013
Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cellsAyae Ikawa-Yoshida, Koji Ando, Eiji Oki, et al.Scientific Reports|May 4, 2016
The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNAHiroyuki Kitao, Yosuke Morodomi, Shinichiro Niimi, et al.Pageof 16